Název: The costs and reimbursements for lung cancer treatment among selected health care providers in the Czech republic
Autoři: Šimrová, Jana
Barták, Miroslav
Vojtíšek, Radovan
Rogalewicz, Vladimír
Citace zdrojového dokumentu: E+M. Ekonomie a Management = Economics and Management. 2014, č. 3, s. 74-85.
Datum vydání: 2014
Nakladatel: Technická univerzita v Liberci
Typ dokumentu: článek
article
URI: http://www.ekonomie-management.cz/download/1411803186_2116/07_THE+COSTS+AND+REIMBURSEMENTS+FOR+LUNG+CANCER+TREATMENT.pdf
http://hdl.handle.net/11025/17570
ISSN: 1212-3609 (Print)
2336-5604 (Online)
Klíčová slova: rakovina plic;zdravotní péče;procesní mapy;úhrada zdravotní péče;náklady
Klíčová slova v dalším jazyce: lung cancer;health care;process maps;health care reimbursement;costs
Abstrakt v dalším jazyce: The objective of the article is to objectivise and assess the costs for the lung cancer therapy from the payer’s (health insurance company) and the healthcare provider’s (hospital) perspective based on information available from several large hospitals and specialised centres. No comprehensive assessment of costs related to the treatment of lung cancers at all stages has been published in the Czech Republic to-date. The results in this study are calculated based on diagnostic and therapeutic algorithms, i.e. process maps. These, in turn, are derived from the recommended therapeutic procedures issued by the Masaryk Institute of Oncology, the University Hospital in Hradec Králové and the University Hospital in PlzeÀ. In total, the costs and reimbursements were calculated for 32 utilized algorithms, i.e. process maps. The costs for therapeutic processes account for 22 results, while 10 results correspond to diagnostic processes. Both direct and indirect costs were included in individual calculations. The calculations imply that treatment costs significantly differ depending on the selected diagnostic and therapeutic procedure. It becomes apparent that the setting of the reimbursement system presently generates different stimuli for providers, who may reach both positive and negative balances. This fact, in turn, may have an effect on the economic result leading, in its consequence, to the preference of more suitable alternatives in terms of reimbursement regardless of the optimum procedures for the particular patient. This fact is, to a certain extent, reflected by the reimbursements calculated by means of the DRG system. The given algorithms may potentially be used by health care providers to reach working costs, which will allow accurate calculations for particular hospitals.
Práva: © Technická univerzita v Liberci
CC BY-NC 4.0
Vyskytuje se v kolekcích:Číslo 3 (2014)
Číslo 3 (2014)

Soubory připojené k záznamu:
Soubor Popis VelikostFormát 
07_THE COSTS AND REIMBURSEMENTS FOR LUNG CANCER TREATMENT.pdfPlný text296,46 kBAdobe PDFZobrazit/otevřít


Použijte tento identifikátor k citaci nebo jako odkaz na tento záznam: http://hdl.handle.net/11025/17570

Všechny záznamy v DSpace jsou chráněny autorskými právy, všechna práva vyhrazena.